Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes

NCT03396484 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
NIH
Sponsor class

Stopped Study not begun due to continued laboratory work on the feasibility of outcome measures.

Conditions

Interventions

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)